- Home
- SWIN vs TPST Comparison
SWIN vs TPST Comparison
Compare SWIN & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- TPST
- Stock Information
- Founded
- SWIN 2017
- TPST 2011
- Country
- SWIN Hong Kong
- TPST United States
- Employees
- SWIN N/A
- TPST N/A
- Industry
- SWIN
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- SWIN
- TPST Health Care
- Exchange
- SWIN Nasdaq
- TPST Nasdaq
- Market Cap
- SWIN 214.1M
- TPST 33.0M
- IPO Year
- SWIN 2023
- TPST N/A
- Fundamental
- Price
- SWIN $3.93
- TPST $7.54
- Analyst Decision
- SWIN
- TPST Hold
- Analyst Count
- SWIN 0
- TPST 3
- Target Price
- SWIN N/A
- TPST $30.00
- AVG Volume (30 Days)
- SWIN 208.1K
- TPST 94.0K
- Earning Date
- SWIN 08-21-2025
- TPST 08-11-2025
- Dividend Yield
- SWIN N/A
- TPST N/A
- EPS Growth
- SWIN N/A
- TPST N/A
- EPS
- SWIN N/A
- TPST N/A
- Revenue
- SWIN $3,316,000.00
- TPST N/A
- Revenue This Year
- SWIN $29.79
- TPST N/A
- Revenue Next Year
- SWIN $54.60
- TPST N/A
- P/E Ratio
- SWIN N/A
- TPST N/A
- Revenue Growth
- SWIN N/A
- TPST N/A
- 52 Week Low
- SWIN $1.16
- TPST $5.35
- 52 Week High
- SWIN $4.40
- TPST $28.34
- Technical
- Relative Strength Index (RSI)
- SWIN 62.05
- TPST 56.78
- Support Level
- SWIN $3.70
- TPST $7.13
- Resistance Level
- SWIN $3.99
- TPST $8.75
- Average True Range (ATR)
- SWIN 0.35
- TPST 0.47
- MACD
- SWIN -0.03
- TPST 0.12
- Stochastic Oscillator
- SWIN 93.02
- TPST 54.17
About SWIN Solowin Holdings
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.